Recent Security Class Actions

Bolt Biotherapeutics Inc. Common Stock (NASDAQ: BOLT)

49 Days left to seek lead plaintiff status.

Company Name:Bolt Biotherapeutics Inc. Common Stock
Stock Symbol:NASDAQ: BOLT
Class Period Start:02/05/2021
Class Period End (inclusive):05/14/2024
Filing Deadline:09/03/2024

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) BDC-1001 was less effective than the Company had represented to investors and was in fact unlikely to meet its pre-defined success criteria; (ii) accordingly, Defendants overstated the clinical and/or commercial prospects of Bolt's product pipeline, on which the Company primarily relies to sustain its business model; (iii) all of the foregoing subjected the Company to a heightened risk of disruptive leadership transitions and substantial workforce reduction; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Bolt Biotherapeutics Inc. Common Stock (NASDAQ: BOLT) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.